1887
  1. Home
  2. Eurosurveillance
  3. Volume 31, Issue 11, 19/Mar/2026
  4. Article
Research Open Access
Like 0
Download

SDG 3: Tuberculosis

Abstract

BACKGROUND

In tuberculosis (TB) surveillance, genomics is mainly used to identify TB patient clusters; growing clusters are commonly attributed to ongoing transmission events.

AIM

This study’s objective was to explore other factors, in addition to ongoing transmission, contributing to cluster expansion.

METHODS

The study population included all 1,886 culture-positive TB cases diagnosed within the whole Almería province population, Spain, between January 2003 and June 2024. Cases’ strains were whole genome sequenced enabling detection of clusters (with pairwise distance between strains < 12 single nucleotide polymorphisms (SNPs)). Evolutionary analyses positioned cases within genomic networks based on SNP distribution. This allowed, together with clinical and epidemiological data, to infer why new cases (diagnosed 3.5 years prior) entered clusters.

RESULTS

Cases’ mean age was 37.3 years (standard deviation: 16.4); 71.7% (1,352/1,886) were male and 65.2% (1,230/1,886) migrants from 50 countries, with mostly Moroccan (21.6%; 407/1,886), Romanian (10%; 188/1,886), Senegalese (8.3%; 156/1,886) and Malian (5.2%; 98/1,886) nationalities. We detected 106 clusters, comprising 537 cases in total. The 106 new cases occurred within 53 clusters, including 31 growing clusters (identified pre-2021) and 22 recent clusters (that arose in 2021 and after). Ongoing transmission was responsible for cluster expansion in around one-third of growing clusters (9/31), versus two-thirds (15/22) of recent clusters. Genomic network assessments found that newly clustered cases not due to ongoing transmission, were likely driven by reactivation of past exposures, prolonged diagnostic delays or subclinical periods, or a combination of these factors.

CONCLUSION

Understanding cluster dynamics guides case-specific management and supports TB control.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2026.31.11.2500301
2026-03-19
2026-04-19
/content/10.2807/1560-7917.ES.2026.31.11.2500301
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/31/11/eurosurv-31-11-2.html?itemId=/content/10.2807/1560-7917.ES.2026.31.11.2500301&mimeType=html&fmt=ahah

References

  1. Walker TM, Ip CLC, Harrell RH, Evans JT, Kapatai G, Dedicoat MJ, et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis. 2013;13(2):137-46.  https://doi.org/10.1016/S1473-3099(12)70277-3  PMID: 23158499 
  2. Meehan CJ, Goig GA, Kohl TA, Verboven L, Dippenaar A, Ezewudo M, et al. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. Nat Rev Microbiol. 2019;17(9):533-45.  https://doi.org/10.1038/s41579-019-0214-5  PMID: 31209399 
  3. Salvato RS, Reis AJ, Schiefelbein SH, Gómez MAA, Salvato SS, da Silva LV, et al. Genomic-based surveillance reveals high ongoing transmission of multi-drug-resistant Mycobacterium tuberculosis in Southern Brazil. Int J Antimicrob Agents. 2021;58(4):106401.  https://doi.org/10.1016/j.ijantimicag.2021.106401  PMID: 34289403 
  4. Abascal E, Pérez-Lago L, Martínez-Lirola M, Chiner-Oms Á, Herranz M, Chaoui I, et al. Whole genome sequencing-based analysis of tuberculosis (TB) in migrants: rapid tools for cross-border surveillance and to distinguish between recent transmission in the host country and new importations. Euro Surveill. 2019;24(4):1800005.  https://doi.org/10.2807/1560-7917.ES.2019.24.4.1800005  PMID: 30696526 
  5. Guthrie JL, Strudwick L, Roberts B, Allen M, McFadzen J, Roth D, et al. Comparison of routine field epidemiology and whole genome sequencing to identify tuberculosis transmission in a remote setting. Epidemiol Infect. 2020;148:e15.  https://doi.org/10.1017/S0950268820000072  PMID: 32014080 
  6. Walker TM, Monk P, Smith EG, Peto TEA. Contact investigations for outbreaks of Mycobacterium tuberculosis: advances through whole genome sequencing. Clin Microbiol Infect. 2013;19(9):796-802.  https://doi.org/10.1111/1469-0691.12183  PMID: 23432709 
  7. Álamo Vera V. Tuberculosis en Andalucía. Informe del año 2024. Monografía. 2025;30(7).
  8. Alonso M, Herranz M, Martínez Lirola M, González-Rivera M, Bouza E, García de Viedma D, INDAL-TB Group. Real-time molecular epidemiology of tuberculosis by direct genotyping of smear-positive clinical specimens. J Clin Microbiol. 2012;50(5):1755-7.  https://doi.org/10.1128/JCM.00132-12  PMID: 22378907 
  9. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006;44(12):4498-510.  https://doi.org/10.1128/JCM.01392-06  PMID: 17005759 
  10. Martínez-Lirola M, Herranz M, Buenestado Serrano S, Rodríguez-Grande C, Dominguez Inarra E, Garrido-Cárdenas JA, et al. A One Health approach revealed the long-term role of Mycobacterium caprae as the hidden cause of human tuberculosis in a region of Spain, 2003 to 2022. Euro Surveill. 2023;28(12):1-11.  https://doi.org/10.2807/1560-7917.ES.2023.28.12.2200852  PMID: 36951787 
  11. Comas I, Chakravartti J, Small PM, Galagan J, Niemann S, Kremer K, et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet. 2010;42(6):498-503.  https://doi.org/10.1038/ng.590  PMID: 20495566 
  12. Xu Y, Cancino-Muñoz I, Torres-Puente M, Villamayor LM, Borrás R, Borrás-Máñez M, et al. High-resolution mapping of tuberculosis transmission: Whole genome sequencing and phylogenetic modelling of a cohort from Valencia Region, Spain. PLoS Med. 2019;16(10):e1002961.  https://doi.org/10.1371/journal.pmed.1002961  PMID: 31671150 
  13. Verza M, Scheffer MC, Salvato RS, Schorner MA, Barazzetti FH, Machado HM, et al. Genomic epidemiology of Mycobacterium tuberculosis in Santa Catarina, Southern Brazil. Sci Rep. 2020;10(1):12891.  https://doi.org/10.1038/s41598-020-69755-9  PMID: 32732910 
  14. Litvinjenko S, Magwood O, Wu S, Wei X. Burden of tuberculosis among vulnerable populations worldwide: an overview of systematic reviews. Lancet Infect Dis. 2023;23(12):1395-407.  https://doi.org/10.1016/S1473-3099(23)00372-9  PMID: 37696278 
  15. Nelson KN, Talarico S, Poonja S, McDaniel CJ, Cilnis M, Chang AH, et al. Mutation of Mycobacterium tuberculosis and Implications for Using Whole-Genome Sequencing for Investigating Recent Tuberculosis Transmission. Front Public Health. 2022;9:790544.  https://doi.org/10.3389/fpubh.2021.790544  PMID: 35096744 
  16. Almatrafi MA, Awad K, Alsahaf N, Tayeb S, Alharthi A, Rabie N, et al. Disseminated Tuberculosis Post COVID-19 Infection: A Case Report. Cureus. 2022;14(11):e31489.  https://doi.org/10.7759/cureus.31489  PMID: 36532934 
  17. Ford CB, Lin PL, Chase MR, Shah RR, Iartchouk O, Galagan J, et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet. 2011;43(5):482-6.  https://doi.org/10.1038/ng.811  PMID: 21516081 
  18. Lillebaek T, Norman A, Rasmussen EM, Marvig RL, Folkvardsen DB, Andersen ÅB, et al. Substantial molecular evolution and mutation rates in prolonged latent Mycobacterium tuberculosis infection in humans. Int J Med Microbiol. 2016;306(7):580-5.  https://doi.org/10.1016/j.ijmm.2016.05.017  PMID: 27296510 
  19. Colangeli R, Arcus VL, Cursons RT, Ruthe A, Karalus N, Coley K, et al. Whole genome sequencing of Mycobacterium tuberculosis reveals slow growth and low mutation rates during latent infections in humans. PLoS One. 2014;9(3):e91024.  https://doi.org/10.1371/journal.pone.0091024  PMID: 24618815 
  20. Bryant JM, Schürch AC, van Deutekom H, Harris SR, de Beer JL, de Jager V, et al. Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome sequencing data. BMC Infect Dis. 2013;13(1):110.  https://doi.org/10.1186/1471-2334-13-110  PMID: 23446317 
  21. Migliori GB, Langendam MW, D’Ambrosio L, Centis R, Blasi F, Huitric E, et al. Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones. Eur Respir J. 2012;40(4):814-22.  https://doi.org/10.1183/09031936.00036812  PMID: 22653774 
  22. Devasia RA, Blackman A, Gebretsadik T, Griffin M, Shintani A, May C, et al. Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure. Am J Respir Crit Care Med. 2009;180(4):365-70.  https://doi.org/10.1164/rccm.200901-0146OC  PMID: 19483111 
  23. Long R, Chong H, Hoeppner V, Shanmuganathan H, Kowalewska-Grochowska K, Shandro C, et al. Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis. Clin Infect Dis. 2009;48(10):1354-60.  https://doi.org/10.1086/598196  PMID: 19348594 
  24. Yin J, Yan G, Qin L, Zhu C, Fan J, Li Y, et al. Genomic investigation of bone tuberculosis highlighted the role of subclinical pulmonary tuberculosis in transmission. Tuberculosis (Edinb). 2024;148:102534.  https://doi.org/10.1016/j.tube.2024.102534  PMID: 38909563 
  25. Sanz-Pérez A, Rodríguez-Grande C, Buenestado-Serrano S, Martínez-Lirola M, Herranz-Martín M, Peñas-Utrilla D, et al. Reducing delays in the genomic epidemiology of tuberculosis: a flexible and decentralized analysis of each incident case. Unpublished. 2024.
  26. Goig GA, Cancino-Muñoz I, Torres-Puente M, Villamayor LM, Navarro D, Borrás R, et al. Whole-genome sequencing of Mycobacterium tuberculosis directly from clinical samples for high-resolution genomic epidemiology and drug resistance surveillance: an observational study. Lancet Microbe. 2020;1(4):e175-83.  https://doi.org/10.1016/S2666-5247(20)30060-4  PMID: 35544271 
  27. Nilgiriwala K, Rabodoarivelo MS, Hall MB, Patel G, Mandal A, Mishra S, et al. Genomic Sequencing from Sputum for Tuberculosis Disease Diagnosis, Lineage Determination, and Drug Susceptibility Prediction. J Clin Microbiol. 2023;61(3):e0157822.  https://doi.org/10.1128/jcm.01578-22  PMID: 36815861 
Long-term refined genomic analysis of tuberculosis clusters to distinguish between ongoing transmission, reactivations or diagnostic delays, Almería, Spain, 2003 to 2024
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Cristina+Rodr%C3%ADguez-Grande&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Rodríguez-Grande Cristina</a>, <a href="/search?value1=Silvia+Vallejo-Godoy&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vallejo-Godoy Silvia</a>, <a href="/search?value1=Miguel+Mart%C3%ADnez-Lirola&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Martínez-Lirola Miguel</a>, <a href="/search?value1=Sheri+M.+Saleeb&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Saleeb Sheri M.</a>, <a href="/search?value1=Marta+Herranz&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Herranz Marta</a>, <a href="/search?value1=Sergio+Buenestado-Serrano&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Buenestado-Serrano Sergio</a>, <a href="/search?value1=Andrea+Marcos-Abell%C3%A1n&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Marcos-Abellán Andrea</a>, <a href="/search?value1=Pilar+Barroso-Garc%C3%ADa&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Barroso-García Pilar</a>, <a href="/search?value1=Senay+Rueda+Nieto&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Rueda Nieto Senay</a>, <a href="/search?value1=Francisca+Escabias-Machuca&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Escabias-Machuca Francisca</a>, <a href="/search?value1=Ana+Bel%C3%A9n+Esteban-Garc%C3%ADa&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Esteban-García Ana Belén</a>, <a href="/search?value1=Mar%C3%ADa+Teresa+Cabezas+Fern%C3%A1ndez&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Cabezas Fernández María Teresa</a>, <a href="/search?value1=Jos%C3%A9+Antonio+Garrido-C%C3%A1rdenas&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Garrido-Cárdenas José Antonio</a>, <a href="/search?value1=Patricia+Mu%C3%B1oz&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Muñoz Patricia</a>, <a href="/search?value1=Laura+P%C3%A9rez-Lago&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Pérez-Lago Laura</a>, <a href="/search?value1=Dar%C3%ADo+Garc%C3%ADa+de+Viedma&option1=author&noRedirect=true" class="nonDisambigAuthorLink">García de Viedma Darío</a></span>. Long-term refined genomic analysis of tuberculosis clusters to distinguish between ongoing transmission, reactivations or diagnostic delays, Almería, Spain, 2003 to 2024. <a href="/content/ecdc">Euro Surveill.</a> 2026;31(11):pii=2500301. <a href="https://doi.org/10.2807/1560-7917.ES.2026.31.11.2500301" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2026.31.11.2500301</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 01 May 2025;&nbsp;&nbsp; <span class="generated">Accepted</span>: 12 Oct 2025 </span> </p>
/content/10.2807/1560-7917.ES.2026.31.11.2500301
/content/10.2807/1560-7917.ES.2026.31.11.2500301
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error